Skip to main content
Erschienen in: Current Cardiology Reports 5/2016

01.05.2016 | Pericardial Disease (AL Klein, Section Editor)

Transient Constrictive Pericarditis: Current Diagnostic and Therapeutic Strategies

verfasst von: James Gentry, Allan L. Klein, Christine L. Jellis

Erschienen in: Current Cardiology Reports | Ausgabe 5/2016

Einloggen, um Zugang zu erhalten

Abstract

Transient constrictive pericarditis is increasingly recognized as a distinct sub-type of constrictive pericarditis. The underlying pathophysiology typically relates to impaired pericardial distensibility, associated with acute or sub-acute inflammation, rather than the fibrosis or calcification often seen in chronic pericardial constriction. Accordingly, patients may present clinically with concomitant features of pericarditis and constrictive physiology. Non-invasive multimodality imaging is advocated for diagnosis of transient constrictive pericarditis. Echocardiography remains the mainstay for initial evaluation of the dynamic features of constriction. However, cardiac magnetic resonance imaging can provide complimentary functional information, with the addition of dedicated sequences to assess for active pericardial edema and inflammation. Although transient pericardial constriction can spontaneously resolve, institution of anti-inflammatory therapy may hasten resolution or even prevent progression to chronic pericardial constriction. Non-steroidal anti-inflammatory agents remain the initial treatment of choice, with subsequent consideration of colchicine, steroids, and other immune-modulating agents in more refractory cases.
Literatur
1.
Zurück zum Zitat Sagrista-Sauleda J, Permanyer-Miralda G, Candell-Riera J, Angel J, Soler-Soler J. Transient cardiac constriction: an unrecognized pattern of evolution in effusive acute idiopathic pericarditis. Am J Cardiol. 1987;59:961–6.CrossRefPubMed Sagrista-Sauleda J, Permanyer-Miralda G, Candell-Riera J, Angel J, Soler-Soler J. Transient cardiac constriction: an unrecognized pattern of evolution in effusive acute idiopathic pericarditis. Am J Cardiol. 1987;59:961–6.CrossRefPubMed
2.••
Zurück zum Zitat Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921–64. Current and comprehensive European Society of Cardiology guidelines for the diagnosis and management of pericardial diseases.CrossRefPubMed Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2015;36(42):2921–64. Current and comprehensive European Society of Cardiology guidelines for the diagnosis and management of pericardial diseases.CrossRefPubMed
3.
Zurück zum Zitat Maeda K, Saito S, Toda T, Ueno T, Kuratani T, Sawa Y. Transient constrictive pericarditis following cardiac surgery. Ann Thorac Cardiovasc Surg. 2014;20(Suppl):897–900.CrossRefPubMed Maeda K, Saito S, Toda T, Ueno T, Kuratani T, Sawa Y. Transient constrictive pericarditis following cardiac surgery. Ann Thorac Cardiovasc Surg. 2014;20(Suppl):897–900.CrossRefPubMed
4.•
Zurück zum Zitat Feng D, Glockner J, Kim K, et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation. 2011;124:1830–7. Important paper demonstrating the utility of cardiac magnetic resonance imaging in predicting those with constrictive pericarditis who benefit from anti-inflammatory therapy.CrossRefPubMed Feng D, Glockner J, Kim K, et al. Cardiac magnetic resonance imaging pericardial late gadolinium enhancement and elevated inflammatory markers can predict the reversibility of constrictive pericarditis after antiinflammatory medical therapy: a pilot study. Circulation. 2011;124:1830–7. Important paper demonstrating the utility of cardiac magnetic resonance imaging in predicting those with constrictive pericarditis who benefit from anti-inflammatory therapy.CrossRefPubMed
5.
Zurück zum Zitat Allaria A, Michelli D, Capelli H, Berri G, Gutierrez D. Transient cardiac constriction following purulent pericarditis. Eur J Pediatr. 1992;151:250–1.CrossRefPubMed Allaria A, Michelli D, Capelli H, Berri G, Gutierrez D. Transient cardiac constriction following purulent pericarditis. Eur J Pediatr. 1992;151:250–1.CrossRefPubMed
6.
Zurück zum Zitat Woods T, Vidarsson B, Mosher D, Stein JH. Transient effusive-constrictive pericarditis due to chemotherapy. Clin Cardiol. 1999;22:316–8.CrossRefPubMed Woods T, Vidarsson B, Mosher D, Stein JH. Transient effusive-constrictive pericarditis due to chemotherapy. Clin Cardiol. 1999;22:316–8.CrossRefPubMed
7.
Zurück zum Zitat Haley JH, Tajik AJ, Danielson GK, Schaff HV, Mulvagh SL, Oh JK. Transient constrictive pericarditis: causes and natural history. J Am Coll Cardiol. 2004;43:271–5.CrossRefPubMed Haley JH, Tajik AJ, Danielson GK, Schaff HV, Mulvagh SL, Oh JK. Transient constrictive pericarditis: causes and natural history. J Am Coll Cardiol. 2004;43:271–5.CrossRefPubMed
8.
Zurück zum Zitat Imazio M, Brucato A, Maestroni S, et al. Risk of constrictive pericarditis after acute pericarditis. Circulation. 2011;124:1270–5.CrossRefPubMed Imazio M, Brucato A, Maestroni S, et al. Risk of constrictive pericarditis after acute pericarditis. Circulation. 2011;124:1270–5.CrossRefPubMed
9.
Zurück zum Zitat Taylor AM, Dymarkowski S, Verbeken EK, Bogaert J. Detection of pericardial inflammation with late-enhancement cardiac magnetic resonance imaging: initial results. Eur Radiol. 2006;16:569–74.CrossRefPubMed Taylor AM, Dymarkowski S, Verbeken EK, Bogaert J. Detection of pericardial inflammation with late-enhancement cardiac magnetic resonance imaging: initial results. Eur Radiol. 2006;16:569–74.CrossRefPubMed
10.
Zurück zum Zitat Syed FF, Ntsekhe M, Mayosi BM, Oh JK. Effusive-constrictive pericarditis. Heart Fail Rev. 2013;18:277–87.CrossRefPubMed Syed FF, Ntsekhe M, Mayosi BM, Oh JK. Effusive-constrictive pericarditis. Heart Fail Rev. 2013;18:277–87.CrossRefPubMed
11.
Zurück zum Zitat Talreja DR, Edwards WD, Danielson GK, et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation. 2003;108:1852–7.CrossRefPubMed Talreja DR, Edwards WD, Danielson GK, et al. Constrictive pericarditis in 26 patients with histologically normal pericardial thickness. Circulation. 2003;108:1852–7.CrossRefPubMed
12.••
Zurück zum Zitat Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013;26:965–1012 e15. Current recommendations from the American Society of Echocardiography, highlighting the importance of multi-modality imaging in the assessment of pericardial disease.CrossRefPubMed Klein AL, Abbara S, Agler DA, et al. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013;26:965–1012 e15. Current recommendations from the American Society of Echocardiography, highlighting the importance of multi-modality imaging in the assessment of pericardial disease.CrossRefPubMed
13.
Zurück zum Zitat Ha JW, Oh JK, Ling LH, Nishimura RA, Seward JB, Tajik AJ. Annulus paradoxus: transmitral flow velocity to mitral annular velocity ratio is inversely proportional to pulmonary capillary wedge pressure in patients with constrictive pericarditis. Circulation. 2001;104:976–8.CrossRefPubMed Ha JW, Oh JK, Ling LH, Nishimura RA, Seward JB, Tajik AJ. Annulus paradoxus: transmitral flow velocity to mitral annular velocity ratio is inversely proportional to pulmonary capillary wedge pressure in patients with constrictive pericarditis. Circulation. 2001;104:976–8.CrossRefPubMed
14.
Zurück zum Zitat Reuss CS, Wilansky SM, Lester SJ, et al. Using mitral ‘annulus reversus’ to diagnose constrictive pericarditis. Eur J Echocardiogr. 2009;10:372–5.CrossRefPubMed Reuss CS, Wilansky SM, Lester SJ, et al. Using mitral ‘annulus reversus’ to diagnose constrictive pericarditis. Eur J Echocardiogr. 2009;10:372–5.CrossRefPubMed
16.•
Zurück zum Zitat Cremer PC, Tariq MU, Karwa A et al. Quantitative assessment of pericardial delayed hyperenhancement predicts clinical improvement in patients with constrictive pericarditis treated with anti-inflammatory therapy. Circ Cardiovasc Imaging 2015;8. Recent manuscript presenting novel quantitative methods for assessment of pericardial delayed enhancement by cardiac magnetic resonance imaging. Cremer PC, Tariq MU, Karwa A et al. Quantitative assessment of pericardial delayed hyperenhancement predicts clinical improvement in patients with constrictive pericarditis treated with anti-inflammatory therapy. Circ Cardiovasc Imaging 2015;8. Recent manuscript presenting novel quantitative methods for assessment of pericardial delayed enhancement by cardiac magnetic resonance imaging.
17.•
Zurück zum Zitat Imazio M, Brucato A, Cemin R, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369:1522–8. Important manuscript highlighting the benefit of colchicine use in the setting of acute pericarditis.CrossRefPubMed Imazio M, Brucato A, Cemin R, et al. A randomized trial of colchicine for acute pericarditis. N Engl J Med. 2013;369:1522–8. Important manuscript highlighting the benefit of colchicine use in the setting of acute pericarditis.CrossRefPubMed
18.•
Zurück zum Zitat Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118:667–71. Valuable paper addressing the issue of corticosteroid dosing in recurrent pericarditis.CrossRefPubMed Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118:667–71. Valuable paper addressing the issue of corticosteroid dosing in recurrent pericarditis.CrossRefPubMed
19.•
Zurück zum Zitat Jain S, Thongprayoon C, Espinosa RE et al. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis. Am J Cardiol 2015. Recent comprehensive manuscript addressing the benefits and issues related to prescription of anakinra for refractory pericarditis. Jain S, Thongprayoon C, Espinosa RE et al. Effectiveness and Safety of Anakinra for Management of Refractory Pericarditis. Am J Cardiol 2015. Recent comprehensive manuscript addressing the benefits and issues related to prescription of anakinra for refractory pericarditis.
20.
Zurück zum Zitat Scardapane A, Brucato A, Chiarelli F, Breda L. Efficacy of an interleukin-1beta receptor antagonist (anakinra) in idiopathic recurrent pericarditis. Pediatr Cardiol. 2013;34:1989–91.CrossRefPubMed Scardapane A, Brucato A, Chiarelli F, Breda L. Efficacy of an interleukin-1beta receptor antagonist (anakinra) in idiopathic recurrent pericarditis. Pediatr Cardiol. 2013;34:1989–91.CrossRefPubMed
21.
Zurück zum Zitat Finetti M, Insalaco A, Cantarini L, et al. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. J Pediatr. 2014;164:1425–31. e1.CrossRefPubMed Finetti M, Insalaco A, Cantarini L, et al. Long-term efficacy of interleukin-1 receptor antagonist (anakinra) in corticosteroid-dependent and colchicine-resistant recurrent pericarditis. J Pediatr. 2014;164:1425–31. e1.CrossRefPubMed
22.
Zurück zum Zitat Baskar S, Klein AL, Zeft A. The use of IL-1 receptor antagonist (Anakinra) in idiopathic recurrent pericarditis: a narrative review. Cardiology Research and Practice. 2016;2016:1–6.CrossRef Baskar S, Klein AL, Zeft A. The use of IL-1 receptor antagonist (Anakinra) in idiopathic recurrent pericarditis: a narrative review. Cardiology Research and Practice. 2016;2016:1–6.CrossRef
23.
Zurück zum Zitat Imazio M, Gaita F, LeWinter M. Evaluation and treatment of pericarditis: a systematic review. JAMA. 2015;314:1498–506.CrossRefPubMed Imazio M, Gaita F, LeWinter M. Evaluation and treatment of pericarditis: a systematic review. JAMA. 2015;314:1498–506.CrossRefPubMed
Metadaten
Titel
Transient Constrictive Pericarditis: Current Diagnostic and Therapeutic Strategies
verfasst von
James Gentry
Allan L. Klein
Christine L. Jellis
Publikationsdatum
01.05.2016
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 5/2016
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-016-0720-2

Weitere Artikel der Ausgabe 5/2016

Current Cardiology Reports 5/2016 Zur Ausgabe

Cardiovascular Genomics (TL Assimes, Section Editor)

Familial Hypercholesterolaemia in the Era of Genetic Testing

Congenital Heart Disease (RA Krasuski, Section Editor)

Clinical Approaches to the Patient with a Failing Fontan Procedure

Lipid Abnormalities and Cardiovascular Prevention (G De Backer, Section Editor)

CETP Inhibition in CVD Prevention: an Actual Appraisal

Congenital Heart Disease (RA Krasuski, Section Editor)

Choosing Between MRI and CT Imaging in the Adult with Congenital Heart Disease

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.